이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Comparison of Methods to Collect Healthcare Consumption Data of Patients in Clinical Trials With an Economic Evaluation (COMERE)

2017년 1월 3일 업데이트: Assistance Publique - Hôpitaux de Paris

Pragmatic study comparing historical data from usual collection tools to medical administrative databases (local / national PMSI and CRF / SNIIRAM). There are 3 phases to the data collection:

  1. Collection of hospitalization data from the local PMSI and outpatient data from CRF
  2. Collection of hospitalization data in the national PMSI with a probabilistic matching between local and national PMSI data
  3. Collection of outpatient consumption data from SNIIRAM after matching of data from the national PMSI to the SNIIRAM.

연구 개요

상태

알려지지 않은

상세 설명

In studies assessing therapeutic interventions, an economic evaluation requires the collection of patients' healthcare consumption. Two methods are primarily used in accordance with the recommendations of the National Authority for Health (HAS): case report forms (CRF) for ambulatory care and the local hospital discharge databases (local PMSI) - extracted from participating centers - for hospital care. However, these conventional methods have limits. The first is a declarative and mostly retrospective collection, often misinformed and unverifiable. The second provides high quality data but is far from exhaustive as it only concerns hospitalizations that occurred in the participating center, not those that occurred in other hospitals.

In France, medical administrative databases SNIIRAM (all care reimbursed by the statutory health insurance) and national PMSI (all hospital care) are the "gold standards" for collecting consumer personal care. However, the administrative difficulties associated with accessing these databases prevent researchers from extracting routine care consumption data from these databases for health economic studies, despite the fact that the unreliability of the conventional methods has been objectified in a small number of studies in the literature. These studies are few, have been conducted abroad and seek to compare declarative collections to non-exhaustive medical and administrative data. Moreover, they compare only the number of events collected and not the implication for economic evaluations using those numbers, limiting the applicability of their results to economic assessments.

The main objective of this study is to evaluate the performance of usual collection tools compared to the gold standards (medical and administrative databases) for estimating consumption of inpatient and outpatient care in health economic evaluations. The secondary objectives are to evaluate the impact of the potential underestimation of healthcare consumption on the estimated costs and results of economic assessments by studying the variation of the calculated incremental cost-effectiveness ratio (ICER) and the conclusion of evaluation.

The COMERE population comes from studies in which an economic evaluation for an innovative therapeutic strategy was conducted by the principal investigators's research unity. These studies include at the minimum a collection of hospital care consumption. This data collection must be over by the time for the start of the project. The procedure code and studied pathology alone allow the investigators to identify patients in the national PMSI with a probability greater than 0.9. When adding other information available in the local PMSI, this probability reaches 0.99. The principal investigators of the studies agreed on the use of data from their studies in the context of this research project. Overall, among the studies carried out in our unit, 12 projects funded by the Ministry of Health's program supporting funds for expensive innovative technology (STIC) and 1 national registry matched the study's criteria and were retained. Of these 13 studies: 13 have collected data on hospital care consumption and 8 collected data on ambulatory care consumption. In total, these studies included 87 separate centers and 6,928 patients of which 2,661 have an ambulatory care collection. Their data are completely anonymous.

연구 유형

관찰

등록 (실제)

1000

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Paris, 프랑스, 75004
        • Hôpital Hôtel Dieu

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

Patient with an initial hospital stay during which the innovative treatment strategy was implemented

설명

Inclusion Criteria:

Among patients of the source population, patients were included if:

  • Their initial hospital stay (the one during which the innovative treatment strategy was implemented) was found in the local PMSI
  • A probabilistic matching with the national PMSI is possible with a probability equal to 1 (in order to compare the data from the usual collections to the gold standard methods).

Exclusion Criteria:

  • We excluded patients whose initial hospital stay found in the national PMSI was not linkable with other admissions due to a coding error.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
the average ratio of the number of hospital stays collected by the usual method / number collected by the gold standard method
기간: 1 day
the performance of the hospital care consumption collection by the local PMSI: the average ratio of the number of hospital stays (initial and re-hospitalizations) for a patient during the study follow-up period collected through the local PMSI on the number of hospital stays for this patient over the same period collected with the national PMSI.
1 day
the average ratio of the number of ambulatory acts performed for a patient collected by the usual method / number collected by the gold standard method.
기간: 1 day
the performance of the outpatient care consumption by the CRF: the average ratio of the number of ambulatory acts performed for a patient during the study follow-up period collected by the CRF on the number of acts for the same patient extracted from the SNIIRAM over the same period.
1 day

2차 결과 측정

결과 측정
측정값 설명
기간
Ratio of the cost estimated with the conventional method / estimated with the gold standard
기간: 1 day

The secondary endpoints are the following:

  1. The ratio of the cost associated with hospital care consumption estimated using data collected by the usual method (local PMSI) on the cost of that consumption estimated using the gold standard method (national PMSI);
  2. The ratio of the cost associated with outpatient care consumption estimated using data collected by the usual method (CRF) on the cost of that consumption estimated using data collected with the gold standard method (SNIIRAM);
1 day
Variation in the ICER with both methods (%)
기간: 1 day
The secondary endpoints are the following: The change in the ICER, i.e. the difference between the ICER estimated from the usual method of collection and those estimated using the gold standard method
1 day
Proportion of studies in which the conclusion would change
기간: 1day
The secondary endpoints are the following: The proportion of studies in which there is a change in the conclusion when the performance of the tools used to collect care consumption is taken into account, in particular in probabilistic sensitivity analyses
1day
Investigation of the "center" effect and/or "study" effect in the data corresponding to the primary endpoint using intraclass coefficient
기간: 1 day
The secondary endpoints are the following: The search for an effect of the hierarchical data structure ("study" effect and "center" effect) on the extent of the variations observed in the primary endpoint.
1 day

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Karine CHEVREUL, Pr MD PhD, Assistance Publique - Hopitaux de Paris

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2008년 1월 1일

기본 완료 (예상)

2017년 1월 1일

연구 완료 (예상)

2017년 6월 1일

연구 등록 날짜

최초 제출

2016년 12월 12일

QC 기준을 충족하는 최초 제출

2017년 1월 3일

처음 게시됨 (추정)

2017년 1월 5일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2017년 1월 5일

QC 기준을 충족하는 마지막 업데이트 제출

2017년 1월 3일

마지막으로 확인됨

2016년 12월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • PREPS-13-0071

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다